PhinC Development is the expert partner for small to medium sized pharmaceutical or biotech companies, who need to move forward in early drug research.
Thanks to a multidisciplinary team with thorough field experience, PhinC Development helps to take the best decisions concerning drug development using all existing pharmacology and pharmacometrics modeling & simulation (M&S) tools.
PhinC Development offers more rapid and efficient solutions than one-time consulting or CROs.
PhinC Development designs and guides all clinical operations (files, protocols, global development strategy) and coordinates all clinical research actors to optimize your drug development from the drug candidate selection to phase IIb (or later). The application of the MBDD concept "Model Based Drug Development" will significantly optimize the development of your drug candidate at different levels by:
- Providing essential data on the product under study from the earliest stages of development
- Strengthening scientific justifications during regulatory submissions
- Optimizing time and means to implement
PhinC Development brings you the best MBDD tool at each step to go on to the next step efficiently.
- PBPK Physiological Based Pharmacokinetic
- PopPK Population pharmacokinetic
- PKPD Pharmacokinetic/ Pharmacodynamic